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Nectin and nectin-like (Necl) adhesionmolecules are broadly
overexpressed in a wide range of cancers. By binding to these
adhesion molecules, the immunoreceptors DNAX accessory
molecule-1 (DNAM-1), CD96 molecule (CD96), and T-cell
immunoreceptor with Ig and ITIM domains (TIGIT) play a cru-
cial role in regulating the anticancer activities of immune effec-
tor cells. However, within this axis, it remains unclear how
DNAM-1 recognizes its cognate ligands. Here, we determined
the structure of human DNAM-1 in complex with nectin-like
protein-5 (Necl-5) at 2.8 Å resolution. Unexpectedly, we found
that the two extracellular domains (D1–D2) of DNAM-1 adopt
an unconventional “collapsed” arrangement that is markedly
distinct from those in other immunoglobulin-based immunore-
ceptors. The DNAM-1/Necl-5 interaction was underpinned by
conserved lock–and–key motifs located within their respective
D1 domains, but also included a distinct interface derived from
DNAM-1 D2. Mutation of the signature DNAM-1 “key” motif
within the D1 domain attenuated Necl-5 binding and natural
killer cell–mediated cytotoxicity. Altogether, our results have
implications for understanding the bindingmode of an immune
receptor family that is emerging as a viable candidate for cancer
immunotherapy.
The activity of immune effector cells is tightly regulated to
enable the identification and elimination of infected, trans-
formed, or stressed cells while preventing autoimmunity
toward the surrounding healthy tissue. This specificity is
achieved by the coordinated activity of a variety of cell surface–
bound receptors that either stimulate or dampen immune cell
activation. For example, natural killer (NK)3 cell function is
regulated by the integration of signals derived from a variety of
paired receptor families that include the Ly49 receptors in
rodents (1), the killer cell and leukocyte immunoglobulin
receptors (KIRs and LIRs, respectively) in humans (2, 3), and
the CD94-NKG2 (4) andNKR-P1 (5) families in both species.
Within these systems, the inhibitory receptors typically rec-
ognize “self”-molecules that are broadly expressed on the
surface of healthy cells (6–10), while their stimulatory coun-
terparts predominantly bind to nonself or stress-induced
ligands (11–13).
Alternatively, some paired receptor families comprise mem-
bers that exhibit overlapping ligand specificities, and as such
they compete with each other to fine-tune the immune
response. For example, the nectin receptorsDNAM-1 (CD226),
CD96 (TACTILE), andT-cell immunoglobulin and immunore-
ceptor tyrosine-based inhibitory motif (TIGIT) are expressed
on T and NK cells, where they mediate effector/target cell
adhesion and immune synapse formation and regulate effector
function (14). Within this context, DNAM-1 is a stimulatory
receptor that was first identified by its ability to activate T
cells independently of T-cell receptor engagement (15–19).
DNAM-1 has since been shown to be critical for tumor immu-
nosurveillance, as demonstrated in mouse models of chemical-
ly-induced tumors, and by DNAM-1/ mice, which exhibit
accelerated tumor growth (17). In contrast, TIGIT is an inhib-
itory receptor (20–22), and CD96 is able to counter-balance
DNAM-1 function in mice (16), although human CD96 has
been reported to stimulate NK cell cytotoxicity (23).
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Nectin receptor function depends on their capacity to recog-
nize certain nectin and nectin-like (Necl) adhesion molecules,
namely nectin-2 (CD112) and Necl-5 (CD155), which are
broadly overexpressed in a wide range of cancers (24–27). Dur-
ing homeostasis, nectin (like) proteins tether adjacent cells
together via the formation of homo- and heterodimers. These
interactions rely on signature “lock” (AX6G) and “key” (T(F/
Y)P) motifs located within their most membrane distal (D1)
domains (28). The nectin receptors also contain similar lock
and keymotifs within their D1 domains, although they differ in
the complexity of their ectodomains. For example, TIGIT,
DNAM-1, and CD96 possess one, two, and three extracellular
Ig domains, respectively. Structural studies of TIGIT andCD96
have indicated that their D1 domains, which are sufficient for
ligand binding, engage their cognate ligands by a dockingmode
that mimics nectin homo/heterodimerization (29–31). A
recent structure of mouse DNAM-1 bound to human Necl-5
supports this proposition, but it also indicated that the second
DNAM-1 domain (D2) can modulate the interaction (32).
However, the molecular basis underpinning recognition of
Necl-5 by human DNAM-1 remains unclear.
Here, we determined the structure of human DNAM-1 in
complex with one of its cognate ligands, Necl-5. DNAM-1
bound Necl-5 in a 1:1 stoichiometry via a docking mode that
enabled the interaction between lock and key motifs within
their respective D1 domains. The unconventional “collapsed”
architecture of the two extracellular domains of DNAM-1 posi-
tioned the D2 domain such that it made direct contacts with
Necl-5. Binding and functional studies indicated that residues
within DNAM-1 D2 did not modulate the interaction with
ligands or functional response ofDNAM-1 toNecl-5/nectin-2–
expressing target cells. In contrast, theD1-localized key residue
was critical for DNAM-1–dependent ligand binding and NK
cell cytotoxicity. Altogether, these data expand our under-
standing of themolecular features that govern nectin receptor–
ligand interactions.
Results
Structural determination of the DNAM-1/Necl-5 complex
Although the mode of interaction of TIGIT and CD96 with
their cognate ligands has been established (29–31), the struc-
tural basis for humanDNAM-1 ligand recognition is unknown.
To address this gap in our knowledge, we expressed the extra-
cellular Ig domains of human DNAM-1 (D1–D2) and Necl-5
(D1–D3) in human embryonic kidney (HEK)-293S and Hi5
insect cells, respectively. DNAM-1 behaved as a heavily glyco-
sylatedmonomeric species, as judged by its apparentmigration
during SDS-PAGEanalysis and size-exclusion chromatography
(Fig. S1). Necl-5 also appeared to be a glycosylated monomer,
consistent with previous studies (30). To aid in crystallization,
we treated DNAM-1 with endoglycosidase H (endo H), which
trims high-mannose N-glycans that are the only glycoforms
produced by HEK-293S cells to a single N-acetylglucosamine
(GlcNAc) residue, prior to mixing with a 1:1 molar ratio of
Necl-5. Using this approach, we generated crystals of the
DNAM-1/Necl-5 co-complex and determined the structure to
2.8 Å resolution (Table S1). The crystallographic asymmetric
unit comprised two molecules of DNAM-1 and two molecules
of Necl-5 that formed two similar DNAM-1/Necl-5 heterodi-
meric complexes (root mean square deviation (r.m.s.d.) of 1.78
over 430 C atoms). Although one of the DNAM-1/Necl-5
complexes (chains B and D) was relatively poorly resolved, the
electron density for the other heterodimer (chainsA andC)was
clear, allowing the building of the entire polypeptide chains
encompassing the D1 and D2 domains of DNAM-1 (Glu-19–
Ala-241) and the D1–D3 domains of Necl-5 (Glu-27–Val-327),
with the exception of a single loop in DNAM-1 D1 (Ser-84–
Ser-89) and two loopswithinNecl-5D3 (Asp-252–Gln-259 and
Val-302–Thr-308), none of which were located at the DNAM-
1/Necl-5 interface. Indeed, the structure refined well (Fig. S2)
to an Rfactor and Rfree of 20.8 and 23.0%, respectively, thereby
permitting a detailed understanding of the interactions that
governed DNAM-1/Necl-5 recognition.
DNAM-1 comprises an atypical configuration of two tandem
Ig domains
DNAM-1 was composed of two Ig-variable domains that
were tethered together by a relatively long 12-amino acid linker
region (Gln-126–Asn-137) (Fig. 1A). Six individual GlcNAc
residues were visible attached to Asn residues 32, 83, 90, and 97
within D1 and Asn-147 and -186 within D2. The DNAM-1 D1
domainwas composed of one small (sheet I: BED) and one large
(sheet II: AGFCCC) -sheet that were bridged by a single
disulfide bond located between the B- and F-strands (Cys-37–
Cys-108) (Fig. 1B). DNAM-1 D2 was organized similarly to the
D1 domain (r.m.s.d. 2.6 Å over 63 C atoms), whereby it pos-
sessed a canonical disulfide bond, linking the B- and F-strands
(Cys-152–Cys-222). However, within the D2 domain, the
regions equivalent to the C- and D-strand were no longer
H-bonded to sheets I and II, respectively, due in part to an
additional disulfide bond that attached the C-strand to the
C–D linker (Cys-179–Cys-199).
Within theDNAM-1 structure, theD1 andD2 domainswere
collapsed on each other in an unusual side–by–side arrange-
ment, such that the -strands of D1 and D2 formed a single
extended -sheet (Fig. 1, A and B). This unexpected architec-
ture, where D2 was rotated relative to D1 by100°, was facili-
tated by the extended nature of the inter-domain linker that
connected the G-strand of D1 to the A-strand of D2. The
DNAM-1 D1/D2 interface occupied a moderate solvent-inac-
cessible surface area (900 Å2) and was primarily hydrophobic
in nature (Fig. 1C). The core of the interaction zonewas derived
from the A-strand of D1 and the C-strand of D2, where four
contiguousH-bonds between themain chain atoms of Trp-23–
Val-27 (D1) and Ile-173–Leu-175 (D2) formed an anti-parallel
-sheet that stitched the D1 and D2 domains together (Fig. 1D
and Table S2). The interface was further supported by the
DNAM-1 N terminus, where Leu-22–His-24 interacted with
several residues that spanned the length of the C andC strands
of D2 (Fig. 1E).
Notably, the relative juxtapositioning of DNAM-1 domains
is completely distinct to the “beads-on-a-string” arrangement
evident within the nectin (-like) ligands (Fig. 2), to which the
nectin receptors were previously considered to be closely struc-
turally related. Indeed, although many immune receptors are
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composed of multiple tandem Ig domains, the inter-domain
angles are typically large (75°), resulting in either linear
(PD1-L2) (33), perpendicular (LIR-B1) (34), or open V-shaped
(NKp46 and KIR3DL1) (9, 35) configurations (Fig. 2). Among
the immune receptors, the DNAM-1 architecture is most sim-
ilar to that found in FcyRIIA (36), although the rotational angle
betweenD1 andD2domainswithin these two receptors is quite
distinct. Notably, the overall architecture of DNAM-1 reported
here is similar to that of (unliganded) human and mouse
DNAM-1 recently reported by Wang et al. (32) (r.m.s.d. 0.79
and 1.37 Å over 170 and 185 aligned C atoms, respectively),
indicating that this unusual domain configuration represents
the bona fide native state of DNAM-1. Accordingly, DNAM-1
possessed a collapsed side–by–side architecture that is atypical
among immune receptors whose structures have been solved to
date.
Overview of the DNAM-1/Necl-5 heterodimer
DNAM-1 bound exclusively to the D1 domain of Necl-5 via
an extensive interface that buried a total solvent-inaccessible
surface area of1880 Å2 and was characterized by high shape
complementarity (Sc  0.79). Within the complex, Necl-5
adopted a linear configuration of its three Ig domains, such that
the D2 and D3 domains projected away fromDNAM-1 and did
Figure 1. Atypical stacked architecture ofDNAM-1.A, overviewof the structure of humanDNAM-1. The-strands of D1 andD2 are colored in dark and light
blue, respectively, helices are colored red; disulfide bonds are shown as orange sticks, andN-linked glycans are represented by green sticks. Cylinders represent
the axis of inertia of each domain. B, topology diagram of DNAM-1 colored as in A. C, electrostatic surface potential of DNAM-1 D1 and D2 domains (blue,
electropositive; red, electronegative). Residues that are involved in the D1/D2 interface are shown as sticks. D and E, close-up views of the DNAM-1 D1/D2
interface. Dashed lines represent H-bonds.
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not participate in the interaction (Fig. 3A). Although some sub-
tle differences in the inter-domain anglewere evident, the over-
all architecture of Necl-5 was similar to that previously
described for the unbound and CD96-bound forms (Fig. S3)
(28, 30). In this arrangement, theC termini of both receptor and
ligand are positioned at opposing ends of the complex (Fig. 3A).
Accordingly, the DNAM-1/Necl-5 interaction could conceiv-
ably occur either in cis or in trans, i.e. between molecules
located on single or adjacent cellular membranes, respectively
(Fig. 3B). Although a higher-order heterotetrameric arrange-
ment was visible within the crystal lattice (Fig. S4), we do not
consider this to be a physiologically relevant assembly because
the interface was mediated solely by interactions between two
DNAM-1 monomers, and DNAM-1 was judged to be mono-
meric in solution (Fig. S1A).
DNAM-1 D1 binds to Necl-5 via a conserved dockingmode
The DNAM-1/Necl-5 interface was primarily centered
around DNAM-1 D1, which engaged Necl-5 via a head–to–
head docking mode reminiscent of that utilized by TIGIT and
CD96 (Fig. S5) (29, 31). Here, DNAM-1 D1 interacted with
necl-5 in an orthogonal orientation across the breadth of their
respective AGFCCC sheets, giving this region of the interface
a pseudo 2-fold symmetrical appearance (Fig. 3A). The defining
feature of this region of the interface was derived from the lock
and key motifs, whereby aromatic key residues within the F-G
loop of both DNAM-1 (Tyr-113) and Necl-5 (Phe-128) were
inserted into hydrophobic pockets formed by the C–C loops
of their respective binding partner (Fig. 3, C and D, and Table
S3). These interactionswere further stabilized by theC–C loop
of eachmolecule, which flexed inward to enable a single residue
(Gln-57 inDNAM-1 and Ser-74 inNecl-5) tomake interactions
with the G-strand of the binding partner (Fig. 3E). Together,
these twomajor points of contact served to latch the molecules
together at the periphery of the interface. However, residues
located within the central region of this interface also played a
prominent role and accounted for 8 of the 11 total H-bonds
(Fig. 3F). Here, several residues within the central C-, F-, and
G-strands of DNAM-1 and Necl-5 projected directly toward
the opposing sheet where they primarily madeH-bond interac-
tions withmain-chain atoms of their binding partner. Thus, the
D1 domain of DNAM-1 binds to Necl-5 via a conserved dock-
ing topology that is characteristic of the nectin receptor family.
DNAM-1 D2makes direct interactions with Necl-5
In addition to the conventional interface derived from their
respective D1 domains, we observed an interaction site located
between DNAM-1 D2 and Necl-5 D1. This interface contrib-
uted a relatively small fraction (13%) of the total buried surface
area (Fig. 3G) but involved a cluster of direct contacts centered
onAsn-186 ofDNAM-1 (Fig. 3H). Here, Asn-186 lie against the
C–C loop of Necl-5, where it was involved in multiple interac-
tions with the backbone of Gly-70, Glu-71, and Ser-72. Surpris-
ingly, the GlcNAc remnant of the elongatedN-linked glycan of
Asn-186 also made direct interactions with Necl-5, including
an H-bond with Ser-72. The presence of a glycan attached to
Asn-186was clearly supported by the unbiased electron density
(Fig. S6A) and glycopeptide and glycan analyses of recombi-
nantly produced DNAM-1 without prior endo H treatment
(Fig. S6B).
Comparisonwith themouse DNAM-1/Necl-5 structure
Overall, the docking mode of DNAM-1 onto Necl-5 is con-
served between human and mouse DNAM-1 (r.m.s.d. 1.44 Å
over 216 aligned C atoms) (Fig. S7A). However, closer inspec-
tion of the interface reveals several subtle differences. In partic-
ular, of the 22 human DNAM-1 residues that formed interac-
tions with Necl-5, only seven are conserved inmouse DNAM-1
(Fig. S7B). This includes the signature aromatic key (Tyr-113),
which is a phenylalanine in mouse DNAM-1.Within the inter-
face, the differences between mouse and human DNAM-1 are
most obvious in the D2 domain, where the C–D loop, which
lacks a glycan consensus motif in mouse DNAM-1, adopts dis-
tinct conformations within the two structures resulting in
altered interactions with the C–C loop of Necl-5 (Fig. S7A).
Mutations within DNAM-1 D1 but not D2 impact binding to
nectin-2 and Necl-5
Next, to investigate the energetic contribution of DNAM-1
D2 to ligand binding, we first attempted to express the
DNAM-1 D1 domain in isolation. However, we were unable to
produce this truncated protein using mammalian cells, most
probably due to instability associated with the exposure of a
hydrophobic surface that would normally reside at the D1/D2
interface (Fig. 1C). Instead, we generated a panel of DNAM-1
point mutants and assessed their interaction with nectin-2 and
Necl-5 using surface plasmon resonance (SPR). Here, both
Figure 2. Structural comparison of immune receptors that comprisemultiple tandem Ig domains. From left to right, PDB codes: 6O3O (DNAM-1); necl-5
(withdrawn); 3BP5 (PD1-L2); 4NO0 (LIR-B1); 1P6F (NKp46); 3VH8 (KIR3DL1); and 1FCG (FcRIIa).
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Necl-5 and nectin-2 bound to WT HEK-293S produced
DNAM-1 with comparable affinity (KD  1.8 	 0.6 and 2.9 	
0.8 M, respectively) (Fig. 4A). Although we were only able to
couple lower amounts on to the SPR chip, mutation of the
DNAM-1 key residue (Y113A) within the D1 domain drasti-
cally reducednectin-2 andNecl-5 bindingwhen comparedwith
a control mutation (R96A) in a surface-exposed DNAM-1 res-
idue that was distal to the Necl-5–binding site (Fig. 4A). How-
ever, mutations within DNAM-1 D2 that disrupted Asn-186
and its associated N-glycan (N186A) or the glycosylation con-
sensusmotif, defined asNX(S/T),whereX
P (T188A), did not
markedly impact the binding affinity of DNAM-1 for either
nectin-2 or Necl-5 (KD  2.0–2.5 M) (Fig. 4A). To further
confirm that the nature of the glycan chain attached toAsn-186
did not impact the interaction with Necl-5/nectin-2, we also
tested the binding of recombinant DNAM-1 produced inHEK-
293T cells, which was decorated with a variety of complex
N-glycans similar to those that would be expected to occur in
vivo, as opposed to the more homogeneous high-mannose
N-glycans of HEK-293S–produced DNAM-1 (Fig. S6B). How-
ever, the binding of HEK-293T–produced DNAM-1 to Necl-5
and nectin-2 was of similar affinity to DNAM-1 produced in
HEK-293S cells (Fig. 4A).
To further probe the impact of DNAM-1 mutants in a cellu-
lar system, we also tetramerized the biotinylated DNAM-1
mutants and assessed their ability to bind humanmyelogenous
leukemia (K562) cells, which express Necl-5 and nectin-2 (Fig.
4B) by flow cytometry. Althoughnobindingwas observed using
a controlmurine cell line lacking humanDNAM-1 ligands,WT
DNAM-1 bound well to the K562 cells (Fig. 4, C and D). With
the exception of the T188A mutant, which exhibited a 68%
increase in binding, the overall pattern of binding of themutant
or variant forms of DNAM-1 closely matched that obtained
by SPR. The R96A and N186A mutations as well as HEK-
293T–produced DNAM-1 bound equivalently to HEK-293S
DNAM-1, whereas the Y113Amutation reduced binding to the
K562 cells. Thus, the aromatic key residue of DNAM-1 is crit-
ical for the interaction with Necl-5 and nectin-2, whereas Asn-
186 and its associated N-glycan appear to be dispensable for
ligand binding under these experimental conditions.
Mutations within DNAM-1 D1, but not D2, impact NK cell
killing
Finally, to investigate the functional relevance of DNAM-
1/Necl-5 interactions, we transfected WT DNAM-1 (and
mutants thereof) into anNKcell line (NK92) that lacked endog-
enous DNAM-1 expression (Fig. 5A) and co-incubated these
cells with K562 cells at a range of NK/target cell ratios (Fig. 5B).
Analysis of the expression of DNAM-1 in these cell lines dem-
onstrated that DNAM-1N186A could not be detected using the
anti-DNAM-1 antibody 11A8. Thus, we confirmed the expres-
sion of DNAM-1N186A in these cells using nectin-2 tetramers.
Figure 3. DNAM-1–necl-5 complex. A, overview of the structure of DNAM-1 (D1 and D2 colored dark and light blue, respectively) bound to necl-5 (tan). The
aromatic key residues (Tyr-113 in DNAM-1; Phe-128 in necl-5) and N-glycans are labeled and shown as sticks. Asterisks denote the C termini. B, schematic
showing how the DNAM-1/necl-5 complex could exist on the cell surface. C–F, close-up views of the DNAM-1 D1–necl-5 interactions focused on the DNAM-1
key (C), the necl-5 key (D), the C–C loops (E), and the centrally-located residues (F). G, binding footprint of DNAM-1 D1 (dark blue) and D2 (light blue) on necl-5
D1 (tan). H, view of the DNAM-1 D2/necl-5 interface focused on Asn-186. H-bonds are represented by dashed lines.
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Similar to the observations with DNAM-1 tetramer staining of
K562 cells, (Fig. 4C), nectin-2 tetramers bound to eachDNAM-
expressing cell line with the exception of NK92DNAM-1 Y113A
cells (Fig. 5A). Given that NK92 cells preferentially kill via
NKG2D, we performed the killing assays in the presence of the
NKG2D-blocking antibody 1D11. Here, expression of WT
DNAM-1 markedly improved NK cell cytotoxicity compared
with the parental line, indicating that within this experimental
system, killing was DNAM-1–dependent (Fig. 5B). Although
the functional capacity of NK92 cells transduced with the con-
trol R96A DNAM-1 mutant was identical to that of WT
DNAM-1, introduction of the Y113A mutation significantly
reduced killing across all NK/target cell ratios, highlighting the
importance of the conserved aromatic key residue (Fig. 5B). In
contrast, mutations within DNAM-1 D2 (N186A and T188A)
had no effect on NK cell killing at any effector/target cell
ratio (Fig. 5B). Thus, in this NK cell assay, interactions
derived from Asn-186 or its associated N-glycan chain did
not influence DNAM-1–mediated cytotoxicity of nectin-2/
Necl-5–expressing target cells.
Discussion
The nectin receptors are emerging as a critical regulatory
checkpoint governing immune effector function. For example,
overexpression of nectin-2 and Necl-5 on tumors has been
reported to dampen T and NK cell responses via TIGIT and
CD96 (16–19), whereas recognition of these same ligands by
DNAM-1 promotes tumor immunosurveillance and clearance
(15, 37–41). Moreover, DNAM-1 has been associated with a
number of adverse autoimmune pathologies (42–44) and
directly drives the allo-immune response in graft versus host
disease (45). Thus, understanding the factors governing recog-
nition within this paired receptor family has the potential to
Figure 4. Binding studies of DNAM-1 mutants. A, sensorgrams (left) and the corresponding equilibrium binding curves (right) showing the binding of
nectin-2 andnecl-5 to immobilizedDNAM-1 andmutants thereof, as indicated. Sensorgrams and equilibriumbinding curves showone representative of three
(forWTDNAM-1 produced in HEK-293S and HEK-293T) or two (for all others) independent experiments, each performed in duplicate. Equilibrium dissociation
constants (KD)	 S.E. were calculated from the independent experiments. The amount of DNAM-1 coupled to the chip and the predicted maximal response
(Rmax) are indicated for each representative experiment shown.ND indicates not determined. B–D, binding of DNAM-1mutant tetramers to K562 cells. B, K562
cells were stained with nectin-2- and necl-5–specific antibodies as indicated. Histograms of nectin-2 and necl-5 binding are representative of three indepen-
dent experiments. For each panel, the filled black histogram is the isotype control, and the filled gray histogram is the specific antibody. The histograms are
overlaid and are modal between samples. C, binding of WT and mutant DNAM tetramers to K562 cells. Histograms are representative of four independent
experiments. The histograms have been offset and are modal. D, analysis of the median fluorescent intensity of the four independent tetramer staining
experiments. **** indicates p 0.0001 as determined using analysis of variance with Tukey’s post hoc test.
Figure 5. Cytotoxic activity of NK92 cells transduced with DNAM-1 mutants. A, NK92 cells expressing WT and mutant DNAM-1 were generated, and the
expression of DNAM-1 was assessed by flow cytometry using an anti-DNAM-1 antibody (top) or nectin-2 tetramer (bottom). For each panel, the filled black
histogram is either isotype control (top) or streptavidin-PE (bottom), and the filled gray histogram is the specific reagent. The histograms are overlaid and are
modal between samples. B, parental NK92 cells as well as transfected cells expressing full-length DNAM-1 and the mutant forms were used in cytotoxicity
assays. All experimentswere performed in the presence of saturating amounts of anti-NKG2D. NK92 cells expressingDNAM-1 demonstrate increased killing of
K562 cells relative toparental NK92 cells (left panel). Killingof all DNAM-1mutants are shown relative toWTDNAM-1. Significant differences (determinedby the
Mann-Whitney test) at eacheffector/target ratio are indicatedbyasterisks (*,p0.05; **,p0.005). The results from the killing assays arepooled from two (n
6 for NK92, NK92–DNAM-1, NK92–DNAM-1R96A, NK92–DNAM-1Y113A, NK92–DNAM-1N186A) or four (NK92–DNAM-1T188A) independent experiments performed
in triplicate.
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inform future strategies for therapeutic intervention in a range
of human diseases.
Within paired receptor families whose members compete
with each other for ligand binding, the affinity of each receptor
toward any given ligand constitutes a key factor governing the
overall outcome of effector/target cell engagement. Here,
inhibitory receptors are generally considered to bind to ligands
with higher affinity than their activating counterparts, as evi-
denced within the KIRs (46) and the CTLA-4/CD28 (47) recep-
tor systems. This bias favoring inhibition is likely important for
the maintenance of immune tolerance toward healthy tissues
under steady-state conditions. However, our binding data indi-
cate that DNAM-1 binds to its ligands with an affinity in the
same range as that of TIGIT and CD96 (2–10 M) (29, 30).
Thus, the nectin receptor axis likely represents a highly-sensi-
tive system where relatively minor alterations in receptor/li-
gand expression levels could markedly impact immune cell
activation.
The last few years have seen considerable progress in our
understanding of the molecular basis underpinning nectin
receptor recognition, in part due to the determination of mul-
tiple receptor–ligand complexes, including TIGIT/Necl-5 (31),
TIGIT/nectin-2 (29), and CD96-D1/Necl-5 (30). Altogether,
these studies have highlighted the important role that the D1
domain of each receptor, and in particular the lock and key
motifs, plays in ligand binding. However, whereas TIGIT is
composed of only a single Ig domain, DNAM-1 and CD96 pos-
sess two and three Ig domains, respectively, raising questions as
to the evolutionary driving force behind this increased com-
plexity, particularly because the isolated CD96 D1 domain is
sufficient for ligand binding (30).
Here, we extend these findings by reporting the structure of
the entire ectodomain of human DNAM-1 bound to Necl-5.
DNAM-1 adopted an unusual stacked configuration of its two
Ig domains that differedmarkedly from the linear arrangement
observed within the nectin adhesion molecules. This collapsed
architecture placed the D2 domain of DNAM-1 adjacent to
Necl-5, such that Asn-186 and its associated N-glycan made
direct interactions with the C–C loop of the ligand. Although
we were only able to visualize a single GlcNAc moiety at the
interface due to our inability to obtain crystals of natively gly-
cosylated DNAM-1, MS-based glycopeptide and glycan analy-
ses established that Asn-186 of recombinant DNAM-1 was
extensively decorated with a heterogeneous mixture of large,
complex N-glycans. Although our SPR and tetramer staining
experiments demonstrated robust binding of fully glycosylated
DNAM-1 to both nectin-2 and Necl-5, precisely how extended
glycan chains attached to Asn-186 are accommodated at the
relatively tight juncture between DNAM-1 D1, D2, and necl-5
D1 is at this stage unclear. Indeed, mutation of Asn-186 or
removal of its associated N-glycan had no impact on DNAM-1
ligand–binding affinity or DNAM-1–mediated NK cell cyto-
toxicity. In this regard, it is important to note that Arg-185 of
DNAM-1 D2 also makes interactions with Gly-70 of Necl-5.
However, because these contacts were restricted to the main-
chain atoms of the receptor and ligand, we were unable to test
their functional importance usingmutagenesis. Thus, although
at this stage we have no evidence that DNAM-1D2 contributes
to ligand recognition, we cannot exclude this possibility
entirely.
Our data raise new questions regarding the function of the
D2 domain within the nectin receptor family. Because TIGIT
comprises just a single extracellular Ig domain, it seemsunlikely
that the D2 domain is required as a structural scaffold to place
the D1 domain in the appropriate position/orientation for
ligand binding. Whether the D2 domain can impact recogni-
tion of other, as of yet unidentified, nectin receptor ligands or
ancillary molecules that are directly associated with DNAM-1,
such as leukocyte function-associated antigen-1 (LFA-1), will
be an interesting avenue for future investigation. Moreover, it
will also be insightful to identify whether the CD96 D2 domain
adopts a configuration similar to that observed in DNAM-1,
particularly because human CD96 exists as two isoforms that
differ by a 16-residue insertion within the D2 domain, and this
alteration has been reported to modulate Necl-5 binding (48).
Overall, the structure described herein is similar to that of
mouse DNAM-1 bound to human Necl-5 recently reported by
Wang et al. (32). The close overall architecture and binding
affinity of human and mouse DNAM-1 indicate the evolution-
arily conserved nature of this receptor system.However,mouse
and humanDNAM-1 have diverged somewhat in regard to pri-
mary amino acid sequence (53% identity within the ectodo-
main) and indeed the nature of many of the interactions were
distinct. Although the D2 domain of both human and mouse
DNAM-1 made interactions with Necl-5, mouse DNAM-1 did
so via a solitary interaction derived fromGlu-185 (equivalent to
Gly-184 in human DNAM-1), whereas human DNAM-1
formed a more extensive interface that included Arg-185, Asn-
186, and its associated N-glycan. Although the importance of
Glu-185 in mouse DNAM-1/Necl-5 recognition was not for-
mally tested, a truncated DNAM-1 construct comprising
only the D1 domain exhibited reduced binding to Necl-5–
expressing cells, leading the authors to conclude that the D2
domain modulated the interaction with Necl-5. This was in
direct contrast to our binding and functional assays that indi-
cated thatmutation of contact residueswithinDNAM-1D2did
not impact Necl-5 binding or DNAM-1 function. These results
can be reconciled by our observation that we were unable to
express properly folded DNAM-1D1 inmammalian cells, indi-
cating that the D2 domain might be important for stability of
the receptor. Nevertheless, knowledge of these differences
between human and mouse DNAM-1 will be important when
interpreting data from mouse studies.
Experimental procedures
Cell culture
HEK-293T andHEK-293S cellsweremaintained at 37 °C and
5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 4.5 g/liter L-glucose, 0.5 mg/ml penicillin/
streptomycin/L-glutamine (Gibco), and 10% (v/v) heat-inacti-
vated fetal calf serum (FCS) (Sigma). For protein expression,
DMEM was supplemented with 2 mM L-alanyl-L-glutamine
dipeptide (GlutaMAX, Gibco) and nonessential amino acids
(Gibco), and the concentration of FCSwas reduced to 2%. K562
cells were cultured in RPMI 1640 medium supplemented with
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10% FCS, penicillin, and streptomycin. NK92 and NK92 trans-
fectants were cultured in -minimum essential media supple-
mentedwith 20% FCS, 12.5% horse serum, 0.2mM inositol, 0.02
mM folic acid, 5 mM glutamate, 7.5% sodium bicarbonate, 1 M
HEPES (pH7.0), 1.43mM-mercaptoethanol, and 600 units/ml
IL-2. K562 cells were seeded at 1 105 cells/ml and allowed to
divide until cell density reached1 106 cells/ml. NK92 cells
were seeded at 5 105 cells/ml and allowed to divide until cell
density reached 2 106 cells/ml.
Protein expression and purification
The construct encoding human DNAM-1 (amino acids
19–250) was codon-optimized for human expression (Inte-
grated DNATechnologies) and cloned between AgeI and KpnI
restriction sites into the pHLSec vector to include either a
C-terminal hexa-histidine tag (for structural studies) or a con-
sensus site for the biotin protein ligase enzyme (BirA) followed
by a hexa-histidine tag (for SPR and tetramerization). The
human nectin-2 ectodomain (residues 32–350) was cloned in
the same manner. DNAM-1 (and mutants thereof) and nec-
tin-2 were expressed via transient transfection in HEK-293S
cells. For some SPR, tetramer staining, and MS experiments,
WT DNAM-1 was also expressed in HEK-293T cells, where
indicated. The human Necl-5 ectodomain (residues 32–350
and 28–334) was codon-optimized for expression in Trichop-
lusia ni (Integrated DNA Technologies) and cloned into the
pFASTBac vector (Invitrogen) between XhoI and SpeI restric-
tion sites to include a C-terminal hexa-histidine tag. The plas-
mid was incorporated into a recombinant baculovirus, and the
viral titer was expanded in SF9 cells as described in the Bac-to-
Bacmanual (Invitrogen). SolubleNecl-5was obtain by infecting
Hi5 cells with 2% P3 virus. Secreted protein from mammalian
and baculoviral systemswas buffer-exchanged into 10mMTris-
HCl (pH 8.0), 500 mMNaCl and purified via nickel-affinity and
size-exclusion chromatography using a Superdex S200 16/600
column (GE Healthcare) in a buffer comprising 10 mM Tris-
HCl (pH 8.0), 150 mM NaCl. For biotinylation, purified BirA-
tagged DNAM-1 was buffer-exchanged into 10 mM Tris-HCl
(pH 8.0) and biotinylated overnight at 4 °C.
Crystallization and data collection
For crystallization, purified DNAM-1 was enzymatically
digested with endo H in the presence of 10 mM sodium citrate
(pH 5.0) at 4 °C overnight, prior to beingmixedwithNecl-5 in a
1:1 molar ratio at a total concentration of 10 mg/ml. Crystals
were obtained using the hanging-drop vapor diffusion method
using a reservoir solution comprising 20% (v/v) PEG3350, 0.18
mM K2SO4, 10 mM EDTA and were cryo-protected in in the
presence of 10% (v/v) glycerol. X-ray diffraction data were
recorded on a Quantum-315 CCD detector at the MX2 beam-
line of the Australian Synchrotron. Data were integrated by
MOSFLM and scaled using SCALA within the CCP4 suite of
programs. Details of the data-processing statistics are given in
Table S1.
Structure determination and refinement
The structure was determined by molecular replacement
using Phaser. Isolatedmodels for each of theNecl-5D1,D2, and
D3 domains were generated from the unliganded structure
(PDB code 4FQP) (28) using PyMOL (Schrödinger, Inc.) and
used as search models for the D1, D2, and D3 domains of
Necl-5, respectively. Molecular replacement solutions for the
DNAM-1 D1 and D2 domains were obtained using a model
consisting of the isolated nectin-2 D1 (PDB code 5V52) as a
search model. The structure was refined via iterative cycles of
model building in Coot and refinement using Buster (http://
globalphasing.com/buster/).4 N-Linked glycans were manually
incorporated into regions of positive density that correlated to
the requisite sequence motif, NX(S/T), where X is any amino
acid except proline. The final structure comprised two mole-
cules of DNAM-1 and two molecules of Necl-5 within the
asymmetric unit that were arranged into two heterodimers
(heterodimer 1, chainsA andC; heterodimer 2, chains B andD).
Structural analysis was restricted to heterodimer 1 as the elec-
tron density surrounding chains A and C was better defined
than that of chains B and D. The final structure refined to final
Rfactor/Rfree values of 20.8 and 23.0. Details of the refinement
statistics are given in Table S1. The structure factor file and
associated atomic coordinates for the DNAM-1/Necl-5 struc-
ture have been deposited within the Protein Data Bankwith the
accession code 6O3O.
SPR
SPR experiments were performed using a BIAcore 3000 sys-
tem (GE Healthcare) at 25 °C with a buffer comprising 10 mM
Tris-HCl (pH 8.0), 150 mM NaCl, and 0.005% (v/v) surfactant
P20. Varying response units of WT biotinylated DNAM-1 or
mutants thereof (see Fig. 4 for details) were immobilized onto
streptavidin-coated sensor chips (GE Healthcare), and flow
cells were quenched with 10 l of free D-biotin (1 mg/ml) at a
flow rate of 5 l/min prior to injection of analyte. Varying con-
centrations of soluble nectin-2 andNecl-5 were passed over the
flow cells for 30–60 s, in duplicate, at a flow rate of 10 l/min.
The final responses were double-referenced by subtracting
responses from an “empty” flow cell containing biotin-blocked
streptavidin as well as from buffer-only injections. The
responses at equilibrium were used to construct equilibrium
binding curves that fit by a single-site binding model. The cal-
culated equilibrium dissociation constants represent the
mean 	 S.E. of the mean from n  3 (for WT DNAM-1 pro-
duced in HEK-293S and HEK-293T) or n  2 (for all others)
independent experiments. Data were analyzed with Scrub-
ber2.0 (BioLogic Software, Campbell, ACT, Australia) and
Prism 7.0 (GraphPad Software).
FACS analysis
K562 andNK92 cells were harvested andwashed in PBS/FCS
(1%), and Fc receptors were blocked using 10% normal goat
serum. K562 cells were thenwashed and stainedwithDNAM-1
tetramers, anti-CD155 (TX24; Biolegend, San Diego), or anti-
CD112 (TX31; Biolegend) for 30min at 4 °C.After stainingwith
DNAM-1 tetramers, cells were directly fixed by the addition of
paraformaldehyde (10% in PBS) for 20 min at 4 °C. K562 cells
4 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
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stained with antibodies were not fixed. NK92 cells were stained
with anti-DNAM antibody (11A8; Biolegend) or nectin-2
tetramers for 30 min at 4 °C. After staining with nectin-2
tetramers, cells were directly fixed by the addition of parafor-
maldehyde (10% in PBS) for 20 min at 4 °C. After staining/fix-
ation, K562 and NK92 cells were washed twice in PBS/FCS and
prepared for FACS. For acquisition, events were electronically
gated on FSC-A versus FSC-H (singlets), followed by FSC-A
and SSC-A (to exclude doublets and debris). Among the
remaining populations, at least 5000 electronic events of inter-
est were collected using an LSR-II or X-20 Fortessa (BD
Biosciences).
Protein denaturation
The cysteine residues of recombinant human DNAM-1
expressed in HEK293T or HEK-293S cells were reduced using
10 mM aqueous DTT, 45 min at 56 °C, and then carbamidom-
ethylated using 25 mM aqueous iodoacetamide, 30 min in the
dark at 20 °C. The alkylation reaction was quenched using 30
mM aqueous DTT (final concentrations stated).
N-Glycan preparation
All reagents were obtained from Sigma unless otherwise
stated. The water used for all experimental procedures was of
ultra-high purity (MilliQ filtration system, Millipore). The
DNAM-1 N-glycans were released and prepared for glycomics
as described previously (49). In brief, DNAM-1 (20 g) was
immobilized in triplicate spots on a primed 0.45 m polyvi-
nylidene fluoride (PVDF) membrane (Merck-Millipore). The
dried PVDF spots were stained with Direct Blue, excised, trans-
ferred to separate wells in a flat bottom polypropylene 96-well
plate (Corning Life Sciences), blocked with 1% (w/v) polyvi-
nylpyrrolidone in 50% (v/v) aqueous methanol, and washed
with water. De-N-glycosylation was performed using 2 units of
Elizabethkingia miricola N-glycosidase F (Promega) per 20 g
of DNAM-1 in 10 l of water/well, 16 h at 37 °C. The released
N-glycans were transferred into fresh tubes and hydroxylated
by the addition of 100 mM aqueous ammonium acetate (pH 5),
1 h at 20 °C. The glycans were reduced using 1 M sodium boro-
hydride in 50 mM aqueous potassium hydroxide, 3 h at 50 °C.
The reaction was quenched using glacial acetic acid. Dual
desalting of the reduced N-glycans was performed using first
strong cation-exchange resin (where the N-glycans are not
retained) and then porous graphitized carbon (PGC) (where
N-glycans are retained) packed asmicro-columns on top of C18
discs in P10 solid-phase extraction (SPE) formats. The N-gly-
cans were eluted from the PGC micro-columns using 0.05%
trifluoroacetic acid (TFA): 40% acetonitrile (ACN): 59.95%
water (v/v/v), dried, and redissolved in 10 l of water for LC-
MS/MS analysis. Bovine fetuin was included as a sample han-
dling and LC-MS/MS control.
N-Glycan analysis
The N-glycans were separated on a Hypercarb PGC column
(particle size 3m, column length 100mm, inner diameter 0.18
mm, Thermo Fisher Scientific) heated to 27 °C over an 83-min
gradient of 0–45% (v/v) ACN (solvent B) in 10 mM aqueous
NH4HCO3 (solvent A) at a flow of 2 l/min delivered by a
Dionex Ultimate-3000 HPLC (Dionex, CA). The glycans were
detected using an LTQ Velos Pro ion trap mass spectrometer
(Thermo Fisher Scientific) in negative ion polarity mode with a
source voltage of 3.2 kV. The MS1 scan range was m/z 550–
2000 with a zoom scan resolution of m/z 0.25 (FWHM). The
automatic gain control (AGC) for the MS1 scan was 5  104
with a maximum accumulation time of 50 ms. Data-dependent
tandemmass spectrometry (MS/MS) was performed using col-
lision-induced dissociation at a normalized collision energy
(NCE) of 33% of the 10 most abundant precursors in eachMS1
scan. For the MS2 events, the resolution was set to m/z 0.35
(FWHM); the AGC was 2 104, and the maximum accumula-
tion time was 300 ms. Dynamic exclusion was disabled. All MS
and MS/MS spectra were acquired in profile mode. The LC-
MS/MS instrument was tuned and calibrated, and its perfor-
mance was bench-marked using bovine fetuin N-glycans prior
to use. The raw LC-MS/MS data were browsed and annotated
using Xcalibur version 2.2 (Thermo Fisher Scientific) using
assisting software, i.e. GlycoMod and GlycoWorkBench, and
manual de novo glycan sequencing as published previously (50).
The relative abundances of the individual N-glycans were
determined from relative area-under-the-curve (AUC) mea-
surements based on extracted ion chromatograms (EICs) per-
formed for the monoisotopicm/z values using Skyline (51).
N-Glycopeptide preparation
DNAM-1 was digested in solution using 1:30 (w/w, enzyme/
substrate) sequencing-grade porcine trypsin (Promega) in 50
mM aqueous NH4HCO3 (pH 8.4), 16 h at 37 °C. The peptide
mixture was dried and redissolved in 80% ACN, 1% TFA, 19%
water(v/v/v). The tryptic glycopeptides and other hydrophilic
DNAM-1 peptides were enriched using hydrophilic interaction
LC–solid-phase extraction (HILIC-SPE) as described previ-
ously (52). In brief, HILIC-SPE micro-columns (10-mm col-
umn height) were prepared using zwitterionic HILIC (ZIC-
HILIC) silica resin (10-m particle size, 200 Å pore size, kindly
provided by Merck-Millipore) packed into GELoader tips
(Eppendorf) on top of C8 Empore SPE discs. The HILIC-SPE
micro-columns were equilibrated using loading solvent con-
sisting of 80% ACN, 1% TFA, 19% water (v/v/v). The peptide
mixtures were loaded (and reloaded once) on the columns
using an ordinary bench top microcentrifuge operated at low
speed. The retained DNAM-1 peptides were eluted by applying
2 50 l of 1% (v/v) aqueous TFA, dried, and redissolved in 10
l of water for LC-MS/MS analysis.
N-Glycopeptide analysis
The enriched N-glycopeptides were separated on a nano-
flow reversed-phase Helo C18 column (particle size 2.7 m,
column length 100 mm, inner diameter 75 m, Thermo Fisher
Scientific) heated to 50 °C. A gradient over 70 min of 0–60%
(v/v) solvent B (0.1% (v/v) formic acid (FA) inACN)was applied
(solvent A was 0.1% (v/v) aqueous FA). A constant flow rate of
450 nl/min was delivered by an Eksigent nano-400 LC system
(SCIEX). The glycopeptides were detected using an Orbitrap
Elite mass spectrometer (Thermo Fisher Scientific) in positive
polarity mode with a source voltage of 3 kV. The MS1 scan
range wasm/z 500–200; AGC was 1 106, and the maximum
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accumulation time was 50 ms. The 10 most abundant precur-
sors in each MS1 scan were selected for data-dependent
MS/MS acquisition (m/z 110–2000) using higher-energy
C-trap dissociation (HCD) at anNCEof 35%. TheAGCwas 5
104, and the maximum accumulation time was 200 ms for the
HCD-MS/MS events. Dynamic exclusion was enabled with a
maximum repeat count of three for every 30 s. All MS and
MS/MS spectrawere acquired in profilemode. The LC-MS/MS
instrument was tuned and calibrated, and its performance
bench-marked using BSA peptides prior to use. The raw LC-
MS/MS data were browsed and annotated using Xcalibur ver-
sion 2.2 (Thermo Fisher Scientific) using assisting software, i.e.
GPMAW version 10 (Lighthouse Data, Denmark) and Byonic
version 2.3 (Protein Metrics) and manual de novo glycopeptide
sequencing (53). The relative abundances of the individual
N-glycopeptides were determined from relative AUCmeasure-
ments based on monoisotopic m/z EICs performed manually
using Xcalibur version 2.2 (Thermo Fisher Scientific).
Generation NK92–DNAM-1 cell lines
The full-length sequences of WT and mutated DNAM-1 were
cloned into theMSCVplasmid and retroviral supernatants gener-
ated usingHEK-293T cells. ForNK92 transduction, 50g/ml ret-
ronectin was coated onto a nontreated plate for 2 h at room tem-
perature prior to washing (2 times) and blocking with 2% BSA in
PBS for 30 min. Plates were then washed with PBS (2 times), and
viral supernatant was added to the wells after filtration through
0.45-m filters. Virus was adhered to the plates by centrifugation
at 1500  g (2 h at room temperature). Supernatant was then
removed, and the wells were washed with PBS, 0.1% BSA prior to
addition of NK92 cells at 1  106 cells/ml. Cells and virus were
integrated by centrifugation at 200 g for 5min at room temper-
ature. NK92 cells infectedwith retrovirus were sorted on the basis
ofGFPexpression.Populationswere sorteduntil stablewith inser-
tion of DNAM-1 determined by FACS.
NK cell-killing assays
K562 cells were labeled with Cell Trace Violet according to
the manufacturer’s instructions (Thermo Fisher Scientific).
NK92 cells were co-cultured with K562 cells in the presence of
a saturating amount (10 g/ml) of anti-NKG2D antibody
(1D11; Biolegend). Different ratios of cells were added to
U-bottom plates and centrifuged at 1400 rpm for 1 min. The
co-cultures were then incubated for 4 h at 37 °C at which time
theywerewashed and labeledwithZombieNR. For acquisition,
events were electronically gated on FSC-A and SSC-A to detect
live and dead cells. Effectors were excluded in the GFP channel,
and targets were identified on theV450/50 channel. Among the
remaining population in this channel, at least 200 viable elec-
tronic events of interest (CTV/Zombie NR) were collected
using an LSR-II or X-20 Fortessa (BD Biosciences).
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